FDA warns of common blood pressure medicine shortage due to recalls

The FDA is warning of shortages of blood pressure medicines containing valsartan, losartan and irbesartan. A growing list of these drugs have been recalled because they are linked to an increased risk of cancer. .

(CNN)The US Food and Drug Administration is warning of a shortage of a class of drugs used by millions to treat high blood pressure. The drugs known as ARBs, or angiotensin II receptor blockers, contain valsartan.

"Valsartan products are in shortage, and we know that other types of products may fall into shortage soon," FDA Commissioner Dr. Scott Gottlieb and FDA director of drug evaluation and research Dr. Janet Woodcock said in a statement released Friday.
The warning comes as a growing list of the drugs containing valsartan, losartan and irbesartan have been recalled from the market for containing an impurity that presents a cancer risk.